Olive, D. L. (1986). Analysis of clinical fertility trials: a methodologic review. Fertility and Sterility, 45(2), 157-171. https://doi.org/10.1016/s0015-0282(16)49148-x
Olive DL. Analysis of clinical fertility trials: a methodologic review. Fertil Steril. 1986;45(2):157-171. doi:10.1016/s0015-0282(16)49148-x
Olive, D. L. "Analysis of clinical fertility trials: a methodologic review." Fertility and Sterility, vol. 45, no. 2, 1986, pp. 157-171.
For EndNote, Zotero or Mendeley:
License
No open license is recorded for this paper. Reuse terms are set by the publisher.
Author affiliations
1 institution
University of Arkansas for Medical Sciences00xcryt71
Linked to ROR, the Research Organization Registry
RRM Academy Synopsis
Fertility trials without a control group can overstate success
A 1986 review looked at how fertility studies are set up. It drew on psychiatry, liver surgery, and infertility trials from one journal. Uncontrolled psychiatry and liver-surgery studies reported success far more often than controlled ones.
Key Findings
In a review of 52 published uncontrolled trials in psychiatry, 85% reported a therapeutic success. Only 25% of 20 controlled trials did.
Among 53 published studies of a liver-shunt surgery, 75% of the 32 uncontrolled studies reached a strongly favorable conclusion. None of the 6 well-controlled trials did.
Among trials in four sampled years of one journal, 27 came in 1983, more than the other three years combined; only 3 were experimental and 40% had no control group.
Leridon and Spira, cited by the author, projected that among couples unable to conceive for 3 years, pregnancy in the fourth year could be as high as 41% to 48%.
Reviewing 50 non-IVF fertility trials from five later journal volumes, only 15 used life-table analysis; of those, 5 ran no further statistical test.
Interpretation
This methods commentary is not a clinical trial. The author reviewed how fertility studies were designed and analyzed, using findings from psychiatry and liver surgery to show how a missing control group can inflate reported success. The examples show a pattern but do not prove any single fertility study was wrong. The author's own count of trials describes one journal's output over that era. The paper does not test any treatment itself. The paper explains why the way a pregnancy rate is calculated, and whether a study has a control group, changes how much its reported success can be trusted.
RRM Context
This paper predates restorative reproductive medicine (RRM) by decades, but the lessons still apply. RRM outcome studies increasingly report pregnancy over time using life tables, a shift this paper argued for. The author cites Leridon and Spira's estimate that as many as 41% to 48% of long-infertile couples conceive on their own in the fourth year, with no treatment. A treatment's raw success number means little without a comparison group.
Our editorial summary of this paper, not the article's abstract.
To determine whether the surgical diagnosis of endometriosis can be predicted using symptoms, signs, and ultrasound findings. Prospective study (study sample); retrospective record review (test sample). Hospital of Desio (study sample) and Mangiagalli Hospital (test sample), Italy. PATIENT(S): Ninety women scheduled to undergo laparoscopy or laparotomy (study sample); 120 women who underwent laparoscopy (test sample). The study sample group was interviewed before surgery about infertility and dysmenorrhea, dyspareunia, and noncyclic pelvic pain and each member had a pelvic examination and a transvaginal ultrasound. At surgery, endometriosis was noted. For the test sample, the same information was abstracted from medical records after laparoscopy. MAIN OUTCOME MEASURE(S): The ability of symptoms, signs, and ultrasound to predict endometriosis at surgery. A classification tree was developed with the study sample and evaluated with the test sample. RESULT(S): Ovarian endometriosis, but not nonovarian endometriosis, could be reliably predicted with noninvasive tools. Ultrasound and examination best predicted ovarian endometriosis, correctly classifying 100% of cases with no false positive diagnoses in the study sample. Similar results were found in the test sample. CONCLUSION(S): Noninvasive tools may be used to identify women with ovarian, but not nonovarian endometriosis, with excellent agreement with surgical diagnosis.
To assess the efficacy of IVP-ET in infertile women with the polycystic ovary syndrome (PCOS) and to provide a comprehensive review of contemporary therapeutic options and their complications as reflected in the current literature. Pertinent studies in medical literature identified through computerized bibliographic search and via manual review of relevant scientific publications. In vitro fertilization and ET is an effective therapy for PCOS patients who are refractory to ovulation induction in vivo or who have coexisting infertility factors. The use of GnRH agonist (GnRH-a) is associated with significant reductions in the incidence of pregnancy loss and may improve fertilization and cleavage rates. In the PCOS patient, the use of purified FSH preparations does not appear to improve pregnancy rates nor other clinical parameters when compared with hMG. Severe ovarian hyperstimulation syndrome (OHSS) is an important consideration when PCOS patients undergo superovulation protocols. Strategies for OHSS prevention include the use of intravenous albumin immediately after oocyte retrieval, triggering of ovulation with a GnRH-a, or withholding menotropin therapy for several days before hCG administration. Cryopreservation of all embryos for future transfer in an artificial cycle has also proven to be an effective alternative in PCOS patients at high risk for severe OHSS. Pregnancy rates for PCOS patients undergoing IVF-ET are comparable with those for women with tubal factor infertility. Therefore, IVF-ET should be offered to patients with PCOS who are refractory to conventional infertility modalities.
To review, evaluate, and synthesize current published reports assessing the value of abdominal myomectomy in infertile women and those desiring to preserve fertility potential. Major studies dealing with myomectomy were identified through Medline Searches. Those papers reporting the results of myomectomy, factors influencing them, and potential future innovations were obtained. More than half of women not previously pregnant and undergoing myomectomy to preserve childbearing capacity for treatment of recurrent pregnancy wastage or previous infertility conceive. The long duration of infertility before surgery, absence of other factors to explain their not conceiving, and short time interval subsequent to surgery in which conception occurs suggests myomectomy has value in treatment of patients with leiomyomata and otherwise unexplained infertility. The operation carries acceptable risk. Approximately 25% of women undergoing myomectomy have recurrent leiomyomata, but most recurrences are sufficiently delayed to allow adequate opportunity for conception. Abdominal myomectomy is an appropriate alternative to hysterectomy for most women who wish to preserve childbearing potential or enhance it. For the future, myomectomy by endoscopic techniques may hold similar potential.
beta-Endorphin has a role in the regulation of the normal menstrual cycle and possibly in the onset of puberty. We have reviewed the evidence pointing to an alteration in this neuropeptide that may contribute to the pathogenesis of various reproductive dysfunctions. Elevated or high levels of beta-endorphin have been associated with exercise-associated amenorrhea, stress-associated amenorrhea, and polycystic ovarian syndrome. Depressed or low levels of beta-endorphin have been associated with PMS and menopause. Alterations in the levels of beta-endorphin may change the pulsatile release of GnRH via noradrenergic and/or dopaminergic pathways. We have primarily focused on beta-endorphin as representative of the endogenous opioid peptides, but other opioid peptides may also contribute to the pathogenesis of various types of reproductive dysfunction. Perhaps it will become possible to characterize and hone our understanding of the function of beta-endorphin and the other substances composing the endogenous opioid peptides. A better understanding of their role in physiological as well as pathophysiological processes may allow for the development of rational approaches to the treatment of specific disorders pertaining to reproduction. Many questions remain unanswered. Among the most relevant are: what is the precise mechanism of action by which beta-endorphin exerts its influence on pulsatile GnRH release? Is there a functional relationship between CNS and peripheral (serum) levels of beta-endorphin? Are the detected changes in beta-endorphin levels merely associated, or are they a cause of a particular disorder? Since it took almost 40 years between the time prostaglandins were first discovered and eventual realization of their clinical application, it may take some time before the beta-endorphin story is complete.
The recent advent of national family planning programs and the expansion of local programs have created an acute need for accurate statistical evaluation of contraceptive methods. Effectiveness in terms of pregnancy rates and continuation or discontinuation of use of the contraceptive method or methods under study have emerged as the major criteria in such evaluations.
Lack of standardization in analytic methods for assigning infertility data is attributed to inadequate classification of fertility problems, and a lack of consistent methodology in evaluating outcome of infertility therapy. A classification scheme ideally should consider types of fertility problems as well as clinical assessment of its severity. Until an adequate classification system is developed, researchers are encouraged to describe fully the nature of infertility problem examined, and present results for homogenous groups of patients. The life-table method of analysis is a useful technique for assessing infertility statistics. The starting point of this method should depend on the group examined and may be either the date of 1st visit to the clinic or the date that therapy is instituted. Approximate date of conception should be the endpoint. A mathematical model of infertility predicated on the assumption that there is a constant monthly probability of conception of fecundability can be used to derive equations with potential for clinical application.
Tingen C et al., 2003·Environ Health Perspect·Free full text on PubMed Central
Although there has been growing concern about the effects of environmental exposures on human fertility, standard epidemiologic study designs may not collect sufficient data to identify subtle effects while properly adjusting for confounding. In particular, results from conventional time to pregnancy studies can be driven by the many sources of bias inherent in these studies. By prospectively collecting detailed records of menstrual bleeding, occurrences of intercourse, and a marker of ovulation day in each menstrual cycle, precise information on exposure effects can be obtained, adjusting for many of the primary sources of bias. This article provides an overview of the different types of study designs, focusing on the data required, the practical advantages and disadvantages of each design, and the statistical methods required to take full advantage of the available data. We conclude that detailed prospective studies allowing inferences on day-specific probabilities of conception should be considered as the gold standard for studying the effects of environmental exposures on fertility.
Research Methods › Study Design › Randomized Controlled Trials
PMID 3512311 3512311 DOI 10.1016/s0015-0282(16)49148-x 10.1016/s0015-0282(16)49148-x Olive et al. 1986, Olive 1986
Cite this article
Olive, D. L. (1986). Analysis of clinical fertility trials: a methodologic review. Fertility and Sterility, 45(2), 157-171. https://doi.org/10.1016/s0015-0282(16)49148-x
Olive DL. Analysis of clinical fertility trials: a methodologic review. Fertil Steril. 1986;45(2):157-171. doi:10.1016/s0015-0282(16)49148-x
Olive, D. L. "Analysis of clinical fertility trials: a methodologic review." Fertility and Sterility, vol. 45, no. 2, 1986, pp. 157-171.
Keywords
Actuarial Analysis/methods, Clinical Trials As Topic/methods, Female, Humans, Infertility/therapy, Male, Pregnancy, Random Allocation, Research Design, Statistics As Topic